|
2024
|
Invention
|
Modified closed-ended dna (cedna) vectors, compositions, and uses thereof. Described herein are n... |
|
|
Invention
|
Novel lipids and nanoparticle compositions thereof.
Provided herein are lipids having the Formul... |
|
|
Invention
|
Cationic lipids and compositions thereof.
Provided herein are lipids having the Formula I or For... |
|
2023
|
Invention
|
Synthetic single stranded nucleic acid compositions and methods thereof. The present application ... |
|
|
Invention
|
Lipid nanoparticles comprising nculeic acids, ionizable lipids, sterols, lipid anchored polymers ... |
|
|
Invention
|
Novel polyglycerol-conjugated lipids and lipid nanoparticle compositions comprising the same. The... |
|
|
Invention
|
Stealth lipid nanoparticle compositions for cell targeting. e.g.e.g., T cells, B cells, natural k... |
|
|
Invention
|
Lipid nanoparticles comprising nucleic acids and lipid-anchored polymers. Provided herein are lip... |
|
|
Invention
|
Synthetic single-stranded dna molecules and methods of producing and using the same. The present ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of genetic disorders and diseases; genetic medicine... |
|
|
G/S
|
Printed medical publications, namely, reports, manuals, brochures, newsletters, leaflets relating... |
|
|
Invention
|
Cleavable closed-ended dna (cedna) and methods of use thereof. The disclosure provides cleavable ... |
|
|
Invention
|
Lipid nanoparticle compositions and uses thereof. The present disclosure relates to pharmaceutica... |
|
|
Invention
|
Heterologous prime boost vaccine compositions and methods of use. The application describes metho... |
|
2022
|
Invention
|
Scalable and high-purity cell-free synthesis of closed-ended dna vectors. This disclosure provide... |
|
|
Invention
|
Liver-specific expression cassettes, vectors and uses thereof for expressing therapeutic proteins... |
|
|
Invention
|
Single chain variable fragment (scfv) modified lipid nanoparticle compositions and uses thereof. ... |
|
|
Invention
|
Cationic lipids and compositions thereof.
Provided herein are cationic lipids having the Formula... |
|
|
Invention
|
Cationic lipids and compositions thereof. Provided herein are cationic lipids having the Formula ... |
|
|
Invention
|
Apoe and apob modified lipid nanoparticle compositions and uses thereof.
Provided herein are pha... |
|
|
Invention
|
Apoe and apob modified lipid nanoparticle compositions and uses thereof. Provided herein are phar... |
|
|
Invention
|
Non-viral dna vectors for vaccine delivery.
The application describes methods and compositions c... |
|
|
Invention
|
Lyophilized non-viral dna vector compositions and uses thereof.
Provided herein are lyophilized ... |
|
|
Invention
|
Lyophilized non-viral dna vector compositions and uses thereof. Provided herein are lyophilized c... |
|
|
Invention
|
Non-viral dna vectors for vaccine delivery. The application describes methods and compositions co... |
|
|
Invention
|
Non-viral dna vectors expressing therapeutic antibodies and uses thereof.
The application descri... |
|
|
Invention
|
Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof.
The application d... |
|
|
Invention
|
Non-viral dna vectors expressing therapeutic antibodies and uses thereof. The application describ... |
|
|
Invention
|
Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof. The application de... |
|
|
Invention
|
Cationic lipids and compositions thereof. Provided herein are lipids having the Formula I or Form... |
|
|
Invention
|
Non-viral dna vectors and uses thereof for expressing pfic therapeutics.
The application describ... |
|
2021
|
Invention
|
Closed-ended dna vectors and uses thereof for expressing phenylalanine hydroxylase (pah).
Descri... |
|
|
Invention
|
Non-viral dna vectors and uses thereof for expressing fviii therapeutics.
The application descri... |
|
|
Invention
|
Methods for encapsulating polynucleotides into reduced sizes of lipid nanoparticles and novel for... |
|
|
Invention
|
Non-viral dna vectors and uses thereof for expressing gaucher therapeutics.
The application desc... |
|
|
Invention
|
Non-viral dna vectors and uses thereof for expressing factor ix therapeutics.
The application de... |
|
2020
|
Invention
|
Ionizable lipids and nanoparticle compositions thereof.
Provided herein are ionizable lipids rep... |
|
|
Invention
|
Non-viral dna vectors and uses thereof for expressing phenylalanine hydroxylase (pah) therapeutic... |
|
2018
|
G/S
|
Pharmaceutical preparations for the treatment of genetic
disorders and diseases; genetic medicin... |
|
|
G/S
|
Pharmaceutical preparations and genetic medicines for the treatment of genetic disorders, genetic... |
